Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02087228 · ClinicalTrials.gov registry record · NA
Evaluation of the Endometrial Cavity After Endometrial Ablation
A NA study, sponsored by Baylor Research Institute.
- Terminated
- Registry status
- NA
- Development phase
- 25
- Enrollment target
NCT02087228: Clinical Trial NA study, sponsored by Baylor Research Institute.
NCT02087228 is a NA study that was terminated before completion, run by Baylor Research Institute. The registered enrollment target is 25 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02087228, a NA study, was terminated before completion, sponsored by Baylor Research Institute.
- TERMINATED
- Registry status
- NA
- Development phase
- 25 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the shape, size and appearance of the inside of the uterus six months following an endometrial ablation procedure. Half of the participants will have their ablation performed with a hydrothermal ablation device and the other half will have their ablation performed with a device that uses radiofrequency energy.
Primary Outcome
The inside of the uterus will be visualized via hysteroscopy to determine the amount of scarring
Interventions
- DEVICE Genesys HydroTherm Ablator
- DEVICE radiofrequency energy ablation device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2013-09 |
| Est. Completion | 2015-07 |
| Phase | NA |
Why NCT02087228 stopped before completion
NCT02087228 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 25 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 2 interventions - of which Genesys HydroTherm Ablator is the first listed.
NCT02087228 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02087228 about?
NCT02087228 is a clinical study titled "Evaluation of the Endometrial Cavity After Endometrial Ablation". The purpose of this study is to evaluate the shape, size and appearance of the inside of the uterus six months following an endometrial ablation procedure. Half of the participants will have their ablation performed with a hydrothermal ablation device and the other half will have their ablation perf...
What is the current status of trial NCT02087228?
This trial is currently terminated. It is a NA study. The enrollment target is 25 participants. The study started on 2013-09. Estimated completion is 2015-07.
What interventions are being tested in trial NCT02087228?
The interventions under investigation include: Genesys HydroTherm Ablator (DEVICE), radiofrequency energy ablation device (DEVICE).
Who is sponsoring clinical trial NCT02087228?
This trial is sponsored by Baylor Research Institute, which has 180 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02087228's enrollment target sits among peer trials
25 1712th of 2000 higher than 265 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01166854 · 25 participants
Characterization of Familial Myopathy and Paget Disease of Bone
- NCT01913106 · 25 participants · Phase 1
HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer
- NCT02138669 · 25 participants · NA
Intacs Prescription Inserts for Keratoconus Patients
- NCT02174549 · 25 participants · Phase 1
Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia